28 results
DEF 14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Definitive proxy
8:24am
the Carmell SecretomeTM. This proprietary formulation is derived from allogeneic human platelets, which support the body’s own innate regenerative
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
retail consumers. Our product pipeline also includes innovative regenerative bone and tissue healing products that are under development.
Business … the demanding technical requirements of professional care providers and discerning retail consumers. Our product pipeline also includes innovative regenerative
8-K
EX-99.1
32jlciv8k1
16 Jan 24
Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board
7:14pm
8-K/A
EX-99.1
ejfv7kb8o6rz38 2d
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:51pm
8-K
EX-99.1
s9cl21
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:01pm
8-K
EX-99.1
h8gx 1j0gl1qh
15 Nov 23
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
9:54pm
8-K
EX-99.1
22nq9w5jhpdrgeq68
6 Sep 23
Departure of Directors or Certain Officers
4:18pm
8-K/A
EX-99.2
zynqjw84qau4nq74ri6h
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
EX-99.1
b0y3zimrig mfxhg
14 Aug 23
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
7:01am
8-K
EX-99.1
nid 9b2ai4zdepqrf1n9
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
EX-99.2
3ke q30sb6lw7
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
425
6pw540
6 Jul 23
Business combination disclosure
5:15pm
8-K
EX-99.2
xdd5y7to
6 Jul 23
Other Events
5:11pm